Literature DB >> 25346201

Prognostic Factors in Hemodialysis Patients Undergoing Endovascular Treatment for Critical Limb Ischemia due to Isolated Below-the-Knee Disease.

Nobuhiro Suematsu1, Osamu Iida, Mitsuyoshi Takahara, Yasutaka Yamauchi, Yoshimitsu Soga, Masatsugu Nakano, Keisuke Hirano, Daizo Kawasaki, Terutoshi Yamaoka, Kenji Suzuki, Yoshiaki Shintani, Yusuke Miyashita, Junichi Tazaki, Hiroshi Meno, Tetsuji Inou.   

Abstract

AIM: To investigate the prognosis and to clarify the predictors of both patient and limb survival among hemodialysis (HD) patients with critical limb ischemia (CLI) due to isolated below-the-knee (BK) disease.
METHODS: An observational cohort study, analyzing a total of 546 HD patients with 681 limbs who underwent endovascular treatment (EVT) for CLI with isolated BK disease at 11 hospitals in Japan between March 2004 and June 2011, was performed.
RESULTS: The mean patient age was 69.0±9.5 years, and 420 (76.9%) of the subjects were men. The number of patients classified with Rutherford stage 4, 5 and 6 disease was 103 (18.9%), 332 (60.8%) and 111 (20.3%), respectively. The mean HbA1c level was 6.48±1.20%, and 195 (35.7%) of the subjects were active smokers. During the follow-up period (mean: 557.5 days), 191 (35.0%) patients died and 82 (12.0%) limbs underwent major amputation. The freedom from all-cause death was 75.5%, 53.4% and 36.9% and freedom from major amputation was 86.7%, 83.9% and 83.9% at one, three and five years after EVT, respectively. Cox proportional hazard regression analyses revealed that a non-ambulatory status, low serum albumin level and <2 runoff vessels after EVT were significant predictors for both all-cause death and major amputation.
CONCLUSIONS: Although patient survival remains poor, the limb salvage rate after EVT is favorable among those on HD with CLI due to isolated BK disease. The present results allow for the risk stratification of HD patients with CLI undergoing EVT for isolated BK disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25346201     DOI: 10.5551/jat.25056

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  4 in total

1.  Poor survival of dialysis patients with unhealed wounds because of critical limb ischemia: Limb salvage and survival requires wound healing.

Authors:  Hisao Yoshikawa; Shingo Kujime; Masaki Iwasaki; Masao Yoshikawa
Journal:  Int Wound J       Date:  2019-07-19       Impact factor: 3.315

2.  Comparison of Clinical Outcomes after Surgical and Endovascular Revascularization in Hemodialysis Patients with Critical Limb Ischemia.

Authors:  Tatsuya Shiraki; Osamu Iida; Mitsuyoshi Takahara; Yoshimitsu Soga; Shinsuke Mii; Jin Okazaki; Sosei Kuma; Terutoshi Yamaoka; Daisuke Kamoi; Yoshiaki Shintani; Toshinobu Ishikawa; Ikuro Kitano; Masaaki Uematsu
Journal:  J Atheroscler Thromb       Date:  2016-10-13       Impact factor: 4.928

3.  Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.

Authors:  Yujiro Okute; Tetsuo Shoji; Tomoshige Hayashi; Yukinobu Kuwamura; Mika Sonoda; Katsuhito Mori; Atsushi Shioi; Yoshihiro Tsujimoto; Tsutomu Tabata; Masanori Emoto; Masaaki Inaba
Journal:  J Atheroscler Thromb       Date:  2016-09-13       Impact factor: 4.928

4.  Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.

Authors:  Takayasu Ohtake; Yasuhiro Mochida; Kunihiro Ishioka; Machiko Oka; Kyoko Maesato; Hidekazu Moriya; Sumi Hidaka; Satoshi Higashide; Tetsuya Ioji; Yasuyuki Fujita; Atsuhiko Kawamoto; Masanori Fukushima; Shuzo Kobayashi
Journal:  Stem Cells Transl Med       Date:  2018-07-30       Impact factor: 6.940

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.